Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2022-09-01
2023-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Double Flap Technique for Macular Hole
NCT05269563
Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes
NCT04498624
Inverted ILM Repositioning as Treatment for Full Thickness Macular Holes
NCT01228188
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671
ILM Inverted Flap Size in Macular Hole
NCT04683276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
single superior flap technique to secure macular hole closure.
The patients are divided into two groups:
For the first group, the flap will be carried out under the effect of perfluorocarbon.
For the second group, the flap stabilized with methylcellulose.
Surgical intervention
Pars-plana vitrectomy.
Double flap technique to secure macular hole closure.
This arm is NCT05269563, we utilize the results as a comparator to the superior single flap technique.
Surgical intervention
Pars-plana vitrectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical intervention
Pars-plana vitrectomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ibinsina Modern Eye and Retina Center
OTHER
Omer Othman Abdullah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omer Othman Abdullah
Associate consultant ophthalmologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Omer Othman Abdullah
Erbil, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMER 99
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.